Ketamine Is the New Viagra
A combination of high demand and a patent monopoly has created a perfect storm of profitability for Janssen’s Spravato.

A combination of high demand and a patent monopoly has created a perfect storm of profitability for Janssen’s Spravato.
Amid ongoing patent disputes over the mRNA platform, a significant scientific question remains unanswered: whether mRNA itself even is patent eligible.
Recent articles emphasize the need to reform intellectual property protections for government-funded inventions of public health significance.
The Biden Administration could take a number of legal measures to ensure the timely entrance of a generic competitor to Xtandi.
An explanation of the key patents at stake in the intellectual property dispute between Moderna and Pfizer/BioNTech over COVID-19 vaccines.
The Supreme Court seems poised to say that the existence of a secular medical exemption to vaccine mandates means a state must offer a religious exemption.
The promise of COVID vaccines has been unevenly realized: fault lines have emerged between those able to secure doses and those left behind.
Has the global distribution of COVID-19 vaccines been impacted by patent rights? David Gindler and Jasper L. Tran argue that the story is complicated.
For COVID treatments and diagnostics to be broadly available at affordable prices, their IP must be considered a global public good.